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Background: Neural tube defects are congenital malformations of the central 
nervous system. Genetic predisposition and some environmental factors play an 
important role in the development of neural tube defects. This study aimed to 
investigate the effects of diclofenac sodium on the neural tube development in 
a chick embryo model that corresponds to the first month of vertebral deve-
lopment in mammals.
Materials and methods: Seventy-five fertile, specific pathogen-free eggs were 
incubated for 28 h and were divided into five groups of 15 eggs each. Diclofenac 
sodium was administered via the sub-blastodermic route at this stage. Incubation 
was continued till the end of the 48th h. All eggs were then opened and embryos 
were dissected from embryonic membranes and evaluated morphologically and 
histopathologically.
Results: It was determined that the use of increasing doses of diclofenac sodium 
led to defects of midline closure in early chicken embryos. There were statistically 
significant differences in neural tube positions (open or close) among the groups. 
In addition; crown–rump length, somite number were significantly decreased in 
high dose experimental groups compared with control group.
Conclusions: This study showed that development of neurons is affected in chi-
cken embryos after administration of diclofenac sodium. The exact teratogenic 
mechanism of diclofenac sodium is not clear; therefore it should be investigated. 
(Folia Morphol 2019; 78, 2: 307–313)
Key words: diclofenac sodium, chick embryo, neural tube defect, 
development
INTRODUCTION
Non-steroidal anti-inflammatory drugs (NSAIDs) 
are important chemicals in the human body and have 
been widely used for alleviation of pain, inflamma-
tion, myocardial infarction and stroke [22]. NSAIDs 
have different side effects, such as gastrointestinal 
damage, platelet dysfunction and convulsions when 
co-administered with quinolone-derivative antibacte-
rial drugs [11, 36, 42]. Diclofenac sodium (sodium-(O-
((2,6-dichlorophenyl)-amino)-phenyl)-acetate) (DS) is 
a NSAID characterised by a relatively low molecular 
weight, having potent anti-inflammatory, analgesic, 
and antipyretic effects on tissues [35, 37] and used 
commonly by women of reproductive age for treat-
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ment of dysmenorrhoea and menorrhagia [12]. Up to 
20% of women consume prescribed medicine during 
the first trimester of pregnancy; of these medications, 
3% are NSAIDs [28]. DS acts by inhibiting the enzyme 
cyclooxygenase (COX), reducing the arachidonic acid 
release and enhancing its uptake. The COX reaction 
is the rate-limiting step in the formation of prosta-
glandins from arachidonic acid. COX-2, the inducible 
isoform of COX family, is selectively expressed in 
neurons of the cerebral cortex, hippocampus, and 
amygdale. Prostaglandins are important chemical 
mediators in the human body, being involved in both 
normal and abnormal function of virtually every organ 
and system [2, 37].
It was determined that DS crosses from the hu-
man placenta during the first and second trimesters 
to foetus [30, 37]. The fact that DS cross the placental 
barrier to prevent the biosynthesis of prostanoids and 
passes into the foetal circulation causes important 
side effects and sometimes malformations in new-
borns [12, 29, 45]. Some assays determined that the 
DS using throughout the perinatal period may cause 
teratogenic effects on some organs [3, 6, 16, 19]. In 
addition; the use of DS during embryonic develop-
ment of the central nervous system (CNS) can pro-
duce a wide array of neurological dysfunctions and 
neuroanatomical anomalies in animal models [9, 22]. 
However, very little information is available respecting 
DS effects on neurological structures especially with 
regard to prenatal development.
Congenital CNS anomalies are the second most 
prevalent anomalies following congenital cardiovas-
cular anomalies [24]. Neural tube defects (NTD) are an 
important area of congenital malformations. Genetic 
predisposition and some environmental factors play 
a significant role in the development of NTDs. NTDs, 
which occur in approximately 6/10000 newborns, 
create a heterogeneous and complex group of con-
genital anomalies [43].
Neuronal and spinal development stages of chick 
embryo are closely similar to the development stages 
of human embryos. To the best of our knowledge, 
there was no study in the literature that investi-
gates the toxic effects of DS on neural tube (NT) 
development by using chick embryo model. This 
study was designed to fill this gap in knowledge 
and to determine the probable toxic effect of DS 
with respect to different doses. Thereby, it was also 
aimed to determine potential results with its use 
during pregnancy.
MATERIALS AND METHODS
This study was conducted in Afyon Kocatepe Uni-
versity, Department of Anatomy Laboratory. All the 
experiments were performed following ethical guide-
lines established for animal usage by Institutional 
Animal Ethics Committee (IAEC) Afyon Kocatepe Uni-
versity. The 75 eggs were procured from the Veteri-
narian Control and Research Institute, Bornova, Izmir, 
Turkey, 65 ± 5 g in weight, specific pathogen-free 
and day 0 fertilised eggs of white chickens. The eggs 
were placed in the incubator with sharp ends pointing 
down in order to ensure the continuity of the embryos 
and to have them available at the times desired. The 
incubator was kept at a constant temperature range 
of 37.8 ± 0.2ºC and humidity of 60–70%.The eggs 
were automatically rolled every 2 h at a 45° angle to 
the vertical axis during the incubation period. 
The eggs were opened using window procedure 
after 28-h incubation (the embryos reached stage 8 
of development according to Hamburger and Ham-
ilton), and were divided into five groups of 15 eggs 
each (with one control and four experimental groups) 
[20]. Firstly; the egg shell was sterilised with povi-
done-iodine (10%) and then ethanol (70%). A small 
window (1–2 cm) was made aseptically with a spe-
cific technique in the eggshell. The round-shaped 
embryonic disc became visible after the surrounding 
membranes were cut. At this stage; under sterile con-
ditions, DS (Voltaren, 75 mg/3 mL ampoule, Novartis, 
Kartal, Istanbul, Turkey) was diluted in saline and 
prepared in the selected dosages. In humans; the 
recommended daily dose is 50 mg/day. The daily dose 
can be increased to a total of 200 mg/day according 
to the severity of the symptoms. The maximum daily 
dose is 200 mg/day [14, 41]. For animals, 1–18 mg/kg 
DS doses were used in teratogenic studies related 
to pregnancy [3, 6, 19, 44]. A toxic dose of DS was 
5 mg/kg in avian species [1, 33]. Four doses were 
tested: first dose, 1/20 of the toxic dose = 0.25 mg/kg; 
second dose, 1/10 of the toxic dose = 0.5 mg/kg; third 
dose, 1/5 of the toxic dose = 1 mg/kg; and fourth 
dose, 1/2.5 of the toxic dose = 2 mg/kg.
Diclofenac sodium was administered via the sub-
blastodermic route in a volume of 10 µL in groups 
B, C, D and E by Hamilton microinjector (0.25 mg/kg, 
0.5 mg/kg, 1 mg/kg and 2 mg/kg in groups B, C, D and E, 
respectively). Group A served as the control group 
and was administered 10 µL 0.9% NaCl via the sub-
blastodermic route. After treatment, small window 
was sealed with cellophane tape. Then the eggs were 
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hand-turned 180° and placed in the incubator. All 
eggs were opened at the 48th h (Hamburger–Hamilton 
stage 12), and the morphological features of each 
embryo were evaluated under stereomicroscope to 
assess any gross developmental abnormalities [20]. 
Embryos were classified as with defect, normal or 
undeveloped. The samples were then transferred to 
Petri dishes containing 10% formaldehyde solutions 
for histopathological study. The embryos from each 
group were fixed in 10% formaldehyde, dehydrated 
through a graded alcohol series, cleaned in xylene and 
then embedded in paraffin wax. Serial sections of four 
micron thickness were taken from the paraffin blocks 
and stained with haematoxylin and eosin (H&E) dye. 
The sections were examined using a light microscope.
Statistical analysis
Analysis of all findings was performed using the 
Statistical Package for the Social Sciences (SPSS) 
22.0 programme. The data related to NT (open or 
closed) were analysed by using c2 test. The somite 
number, crown–rump length and protein contents 
were analysed by using non-parametric Kruskal-Wallis 
tests. Dunn test were employed as post-hoc tests and 
p < 0.001 were considered significant.
RESULTS
In our study, we investigated the effect of DS at 
different dosages on NT development.
Group A: 15 embryos (100%) in group A were 
expected to be according to Hamburger–Hamilton 
embryonic classification stage 12 and their NTs were 
closed. No malformation or developmental retarda-
tion was observed. The tissue samples observed under 
the light microscope after staining with H&E were 
found to be consistent with the stereomicroscopic 
examination (Fig. 1).
Group B: 7 embryos (46.7%) had NTD and 8 em-
bryos (53.3%) were intact and these embryos sustained 
their normal development and were in the embryonic 
stage 12 where they were expected to be according to 
Hamburger–Hamilton classification (Fig. 2).
Group C: 8 embryos (53.3%) had NTD, 7 embryos 
(46.7%) were intact and their NTs were closed (Fig. 3).
Group D: 13 embryos had NTD (86%) and 2 em-
bryos (14%) were intact and their NTs were closed.
Group E: 15 embryos (100%) had NTD and 1 of 
these embryos was undeveloped and its development 
stage was 9 according to Hamburger–Hamilton em-
bryonic classification (Fig. 4).
There were statistically significant differences 
(p < 0.001) in NT positions (open or close) among 
the groups. The crown–rump length and mean somite 
numbers were diminished in experimental groups ac-
cording to used dosages compared to control group. 
These decreases were determined statistically signifi-
cant (p < 0.001, Table 1).
DISCUSSION
Neural tube defects are serious birth defects of 
the CNS that occur during embryonic development 
when the NT fails to close completely, leading to 
brain and spine anomalies that can lead to death or 
lifelong disability [5]. The period from appearance 
of neural plaque up to closure of palate, i.e. the 
period between 18th day and 60th day of pregnancy, 
is the period where the possibility of congenital 
anomaly is highest, often before women are aware 
Figure 1. A. Normal appearance of post-incubation 2-day chick embryo of group A; B. Histopathologic views of normal chicken embryos 
under light microscope (H&E, ×20); nt — neural tube; n — notochord; s — somites; h — heart.
A B
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Figure 3. A. The neural tube is not closed in the light microscope image of the group C; B. A histologic section was obtained and stained with 
H&E. The neural tube is open in the light microscope image of the same group (H&E, ×20); ont — open neural tube; n — notochord; 
s — somites; h — heart.
Figure 4. A. Developmental retardation seen in the light microscope view of group E; B. The opening in the neural tube is seen in the cervical 
and caudal region of the chick embryo of group E; ont — open neural tube.
A B
BA
Figure 2. A. The opening in the neural tube is seen in the light microscope view of group B; B. A histologic section was obtained and stained 
with H&E. The neural tube is open in the light microscope image of the same group (H&E, ×20); ont — open neural tube; n — notochord; 
s — somites; h — heart.
A B
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they are pregnant. These anomalies originate from 
insufficiency in NT formation or re-opening after 
formation of NT [15, 40]. Genetic and environmen-
tal factors (geographical factors, socio-economic 
factors, alcohol and drug use) can be specified in 
aetiology of NT closure defects [21, 26, 38].
The primary experimental methods of NTD in-
clude amphibian, mammalian, poultry, and computer 
modelling. These models have advantages and dis-
advantages compared to each other. The early chick 
embryo model that corresponds to the first month 
of embryonal development in mammals is an ideal 
modelling [13].
In addition, the studies have demonstrated that 
cytochalasins, papaverine, diazepam, caffeine, etha-
nol, folic acid antagonists such as methotrexate and 
aminopterin, antiepileptic drugs such as phenytoin and 
lacosamide, and local anaesthetics cause NT closure 
defects in early stage chick embryos [4, 18, 23, 25, 39].
It is known that NSAIDs are one of the commonest 
drugs prescribed by general practitioners worldwide, 
and they have been taken during the early concep-
tion period [37]. DS may trigger alterations in the 
CNS morphology having long-term teratogenic ef-
fects on neuronal development [10]. The developing 
CNS is also the most vulnerable to insufficient and 
harmful conditions such as drug exposure during the 
gestational stage [17]; since different parts of the 
CNS form at different stages of development, there 
is not one critical period but many critical periods. 
Some neurons are formed around the time of closure 
of the NT [34].
In this study, possible adverse effect of DS on 
the NT was investigated in chick embryo model. All 
embryos in the control group that were monitored 
under the microscope after 48 h had reached the 
appropriate embryonic stage according to the Ham-
burger–Hamilton method. The effects of DS on the 
embryo were correlated with the dose of DS. It was 
determined that the use of increasing doses of DS 
led to defects of midline closure in early chicken em-
bryos. All embryos had NTD in the high dose group. 
In addition; crown–rump length, somite number were 
significantly decreased in high dose experimental 
groups (groups C, D) compared with control group.
Assays related to DS have reported that its tera-
togenic effect risk is low in case it is used in preg-
nancy, but they are limited. However, the mecha-
nism of embryonic damage related to DS use is 
uncertain [6, 9].
Researchers showed that diclofenac inhibited im-
plantation and embryonic development in rats when 
given on gestation day 5. In this study, rat blastocysts 
were cultured in diclofenac in vitro, then implanted 
to host mothers on day 5 of pseudopregnancy. Large 
doses of diclofenac (75 µg/mL) in culture were toxic. 
Smaller doses (40 µg/mL) had a profound effect on 
implantation. Another group of host mothers received 
diclofenac i.p., 1 h prior to transfer of untreated blas-
tocysts. Control animals had a 72% implantation rate, 
whereas there was only a 35–41% implantation rate 
after in vitro diclofenac treatment. They determined 
that prostaglandin appears to be essential during the 
process of implantation and placentation. When this 
process is disturbed by DS the number of growth-
retarded embryos increases. If DS is such a potent 
inhibitor of prostaglandin synthetase it should be 
expected that decidualisation would also be defec-
tive. In the treated host mothers only 7% of embryos 
were normal, while 34% were growth-retarded [7]. 
Similar to above study; another assay was reported 
a positive correlation between use of NSAID during 
pregnancy and miscarriages [27].
The effect of DS on the developing embryo during 
the critical period of organogenesis was investigated 
by using a whole rat embryo culture model. They ex-
posed to embryos various concentrations of DS and 
scored for growth and differentiation at the end of 
the culture period. It was found that although caudal 
NT, flexion and hind limb were significantly lower 
in embryos exposed high concentration of DS (7.5 
and 15.0 µg/mL); there were no effect low doses of 
Table 1. The statistical analyses embryonic development in control and experimental groups (with diclofenac sodium)
Parameters Group A Group B Group C Group D Group E P
Open NT /Close NT 0/15 7/8 8/7 13/2 15/0 < 0.001*
Crown–rump length [µm] 639.06 ± 105.48 559.42 ± 118.61 540.02 ± 113.86 498.02 ± 83.94 497.62 ± 76.52 < 0.001**, #
Somite number 17.73 ± 1.98 14.73 ± 3.03 14.60 ± 3.73 12.86 ± 3.22 12.86 ± 2.55 < 0.001**, # 
*Chi-square test; **Kruskal-Wallis test; #The difference was determined between group A and group D, group A and group E; NT — neural tube
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it. Based on their results it was suggested that high 
concentration of DS has a teratogenic effect [9]. 
Same researchers thought that the teratogenic effects 
of NSAIDs might be mediated through free oxygen 
radical production. The influence of DS on cellular 
reactive oxygen species production in embryos was 
evaluated by measuring 8 isoprostaglandin F2a level. 
Their results showed that 8-isoprostaglandin F2a level 
was significantly elevated in embryos exposed to high 
concentration of DS (7.5 and 15.0 µg/mL) but no sig-
nificant difference was detected between the control 
and low concentration group (1.5 µg/mL). Embryos 
exposed to the high concentration of DS (15.0 µg/ 
/mL) had a significantly lower total morphology scores 
for caudal NT, hind limb, flexion, and brain. There 
was no significant difference in yolk sac diameter, 
crown–rump length or number of somite between 
experimental and control groups [8]. Free oxygen 
radicals are highly reactive and unstable. In the event 
of oxidative stress, free radicals are in excess, resulting 
in cellular damage. Embryotoxic effects of reactive 
oxygen species may be related to oxidative damage 
to DNA and other cellular macromolecules [31].
Prenatally exposed DS had a neurotoxicity effect 
in the CNS, namely the pyramidal and granular cells 
of hippocampus [17] and Purkinje cells of cerebel-
lum [32]. NSAIDs suppress cell proliferation in the 
spinal cord and dorsal root ganglia by affecting cell 
cycle regulators since it has been shown that DS, in 
contrast to other NSAIDs including aspirin, naproxen, 
indomethacin and ibuprofen, restrains the differ-
entiation of neuronal stem cells into neurons and 
also suppresses cell proliferation via the induction of 
apoptosis. Therefore, DS appears to have some nega-
tive effect on both development and differentiation 
nerve cells [2, 22].
CONCLUSIONS
Consequently, our study has demonstrated that 
DS exerts direct teratogenic effect on the process of 
NT formation of chick embryo in a dose-dependent 
manner. It has also been shown that DS significantly 
decreases the crown–rump length and somite number 
in high dose experimental groups compared with 
control group. The chosen model does not directly 
reflect the environment and conditions of a devel-
oping human embryo. Therefore, it is not possible 
to simply extend and apply the results observed in 
chick embryos to humans. However, the chick embryo 
model has the advantage of allowing the investiga-
tion of potentially hazardous substances directly on 
the embryo. In the present study, we did not use 
specific markers of neurons to see the toxicity induced 
by diclofenac. We interpreted our results based on 
the light of histopathological findings. It is clear that 
improved technical materials and studies with larger 
sample sizes would be useful to confirm the toxic ef-
fects of DS in prenatal period. Further investigation on 
the exact mechanism of diclofenac toxicity would be 
valuable. Present findings cannot serve as definitive 
evidence of the use of DS for embryo-toxicity but it 
does provide an experimental basis for the caution 
of DS use prescription in pregnancy.
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